Trial Profile

Study on Efficacy and Safety of Dexmedetomidine Hydrochloride Nasal Spray for Preoperative Sedation in Adults

Status: Active, no longer recruiting

Phase of Trial: Phase II/III

Latest Information Update: 05 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexmedetomidine (Primary)
Indications Sedation
Focus Registrational; Therapeutic Use
Sponsors Jiangsu Hengrui Medicine Co.

Most Recent Events

14 Jul 2021 Planned End Date changed from 30 May 2021 to 10 Sep 2021.
14 Jul 2021 Status changed from recruiting to active, no longer recruiting.
04 Jan 2021 Planned End Date changed from 30 Oct 2020 to 30 May 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com